Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Fever of 100.5; body felt too hot and too cold intermittently; body aches all over; soreness and swelling at injection site; soreness and swelling at injection site; headache; dizziness; Nausea; brain fog; extreme fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Aug2021 (Lot number: EW0217) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Bicuspid aortic valve" (unspecified if ongoing); "Ascending aortic aneurysm" (unspecified if ongoing); "mild AI" (unspecified if ongoing); "Allergy:tree nuts" (unspecified if ongoing), notes: tree nuts; "Allergy: iodinated diagnostic agents" (unspecified if ongoing), notes: iodinated diagnostic agents; "Allergies: gluten" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL; ATORVASTATIN. Past drug history included: Gentamicin, reaction(s): "Allergies: Gentamicin"; Ciprofloxacin, reaction(s): "Allergies: Ciprofloxacin". Vaccination history included: Bnt162b2 (First dose:lot number=EW0217, vaccine location=Left arm"), administration date: 20Jul2021, when the patient was 44 years old, for Covid-19 Immunisation, reaction(s): "sore at injection sight for 3 days". The following information was reported: PYREXIA (non-serious) with onset 11Aug2021, outcome "recovering", described as "Fever of 100.5"; FEELING OF BODY TEMPERATURE CHANGE (non-serious) with onset 11Aug2021, outcome "recovering", described as "body felt too hot and too cold intermittently"; PAIN (non-serious) with onset 11Aug2021, outcome "recovering", described as "body aches all over"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE SWELLING (non-serious) all with onset 11Aug2021, outcome "recovering" and all described as "soreness and swelling at injection site"; HEADACHE (non-serious) with onset 11Aug2021, outcome "recovering", described as "headache"; DIZZINESS (non-serious) with onset 11Aug2021, outcome "recovering", described as "dizziness"; NAUSEA (non-serious) with onset 11Aug2021, outcome "recovering", described as "Nausea"; FEELING ABNORMAL (non-serious) with onset 11Aug2021, outcome "recovering", described as "brain fog"; FATIGUE (non-serious) with onset 11Aug2021, outcome "recovering", described as "extreme fatigue". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, feeling of body temperature change, pain, vaccination site pain, vaccination site swelling, headache, dizziness, nausea, feeling abnormal, fatigue.  Additional information: Facility type vaccine: Doctor's office/urgent care. Second dose: within 48 hours reported Adverse events occurred. Symptoms are starting to get better on 3rd day after vaccine. COVID prior vaccination: No. COVID tested post vaccination: No. other vaccine in four weeks: No. Other medication taken within 2 weeks of vaccination coded as concomitant medications.  No follow-up attempts are possible. No further information is expected.